Review



rabbit polyclonal antibody against agr2  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Novus Biologicals rabbit polyclonal antibody against agr2
    Rabbit Polyclonal Antibody Against Agr2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against agr2/product/Novus Biologicals
    Average 90 stars, based on 7 article reviews
    rabbit polyclonal antibody against agr2 - by Bioz Stars, 2026-06
    90/100 stars

    Images



    Similar Products

    90
    Novus Biologicals rabbit polyclonal antibody against agr2
    Rabbit Polyclonal Antibody Against Agr2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against agr2/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal antibody against agr2 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    93
    Novus Biologicals nb110 17780 rabbit polyclonal
    Nb110 17780 Rabbit Polyclonal, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nb110 17780 rabbit polyclonal/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    nb110 17780 rabbit polyclonal - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    90
    Novus Biologicals rabbit polyclonal anti satb1 antibody
    <t>SATB1</t> immunohistochemistry staining. A , benign prostate hyperplasia. B , prostatic carcinoma with metastasis. C , prostatic carcinoma without metastasis. D , negative control. Magnification: 400 × .
    Rabbit Polyclonal Anti Satb1 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti satb1 antibody/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti satb1 antibody - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Novus Biologicals rabbit polyclonal antibody
    <t>SATB1</t> immunohistochemistry staining. A , benign prostate hyperplasia. B , prostatic carcinoma with metastasis. C , prostatic carcinoma without metastasis. D , negative control. Magnification: 400 × .
    Rabbit Polyclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal antibody - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Novus Biologicals rabbit polyclonal anti agr2 antibody
    <t>AGR2</t> transcript expression in prostate cancer . Two publically available datasets were used to examine AGR2 gene expression in human prostate samples [ , ]. (A) Dataset was from Yu, et al ., and was generated using Affymetrix U95B Array . (B) Dataset was from Lapointe, et al ., and was generated using a cDNA microarray from the Stanford Microarray Database . For each dataset, normalized data was available from the GEO database. The bars are the relative mean expression value ± standard error of the mean. P < 0.0001 for each multi group comparison (Kruskal-Wallis).
    Rabbit Polyclonal Anti Agr2 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti agr2 antibody/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti agr2 antibody - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    SATB1 immunohistochemistry staining. A , benign prostate hyperplasia. B , prostatic carcinoma with metastasis. C , prostatic carcinoma without metastasis. D , negative control. Magnification: 400 × .

    Journal: Journal of Translational Medicine

    Article Title: SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion

    doi: 10.1186/1479-5876-11-111

    Figure Lengend Snippet: SATB1 immunohistochemistry staining. A , benign prostate hyperplasia. B , prostatic carcinoma with metastasis. C , prostatic carcinoma without metastasis. D , negative control. Magnification: 400 × .

    Article Snippet: The sections were blocked with 2% goat serum in 0.01 M PBS at room temperature for 1 h, then incubated with rabbit polyclonal anti-SATB1 antibody (1:500 dilution, NB110-17780, Novus Biologicals, Littleton, CO, USA) overnight at 4°C.

    Techniques: Immunohistochemistry, Staining, Negative Control

     SATB1  expression and clinicopathologic parameters of prostate cancer

    Journal: Journal of Translational Medicine

    Article Title: SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion

    doi: 10.1186/1479-5876-11-111

    Figure Lengend Snippet: SATB1 expression and clinicopathologic parameters of prostate cancer

    Article Snippet: The sections were blocked with 2% goat serum in 0.01 M PBS at room temperature for 1 h, then incubated with rabbit polyclonal anti-SATB1 antibody (1:500 dilution, NB110-17780, Novus Biologicals, Littleton, CO, USA) overnight at 4°C.

    Techniques: Expressing

    SATB1 expression is correlated with the invasion ability of prostate cancer cells. A - C : The invasion of LNCaP, DU-145 and PC-3 cells was measured by Transwell chamber. A , DU-145. B , PC-3. C , LNCaP. Magnification: 200×. D : Western blot analysis of the relative protein level of SATB1 in LNCaP, DU-145 and PC-3 cells (n = 3). β-actin served as loading control. *P < 0.05 compared to DU-145 cells. Note that SATB1 antibody could not detect SATB2 protein in the cell lysates.

    Journal: Journal of Translational Medicine

    Article Title: SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion

    doi: 10.1186/1479-5876-11-111

    Figure Lengend Snippet: SATB1 expression is correlated with the invasion ability of prostate cancer cells. A - C : The invasion of LNCaP, DU-145 and PC-3 cells was measured by Transwell chamber. A , DU-145. B , PC-3. C , LNCaP. Magnification: 200×. D : Western blot analysis of the relative protein level of SATB1 in LNCaP, DU-145 and PC-3 cells (n = 3). β-actin served as loading control. *P < 0.05 compared to DU-145 cells. Note that SATB1 antibody could not detect SATB2 protein in the cell lysates.

    Article Snippet: The sections were blocked with 2% goat serum in 0.01 M PBS at room temperature for 1 h, then incubated with rabbit polyclonal anti-SATB1 antibody (1:500 dilution, NB110-17780, Novus Biologicals, Littleton, CO, USA) overnight at 4°C.

    Techniques: Expressing, Western Blot, Control

    Silencing of SATB1 in DU-145 cells. DU-145 cells were untransfected (control), transfected with pSliencer3.1 control vector or transfected with pSilencer3.1-SATB1 vector for 24 h, 48 h, or 72 h. The protein levels of SATB1 and SATB2 were detected by Western blot analysis (n = 3). β-actin served as loading control. * P < 0.05 compared to cells transfected with pSliencer3.1.

    Journal: Journal of Translational Medicine

    Article Title: SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion

    doi: 10.1186/1479-5876-11-111

    Figure Lengend Snippet: Silencing of SATB1 in DU-145 cells. DU-145 cells were untransfected (control), transfected with pSliencer3.1 control vector or transfected with pSilencer3.1-SATB1 vector for 24 h, 48 h, or 72 h. The protein levels of SATB1 and SATB2 were detected by Western blot analysis (n = 3). β-actin served as loading control. * P < 0.05 compared to cells transfected with pSliencer3.1.

    Article Snippet: The sections were blocked with 2% goat serum in 0.01 M PBS at room temperature for 1 h, then incubated with rabbit polyclonal anti-SATB1 antibody (1:500 dilution, NB110-17780, Novus Biologicals, Littleton, CO, USA) overnight at 4°C.

    Techniques: Control, Transfection, Plasmid Preparation, Western Blot

    Silencing of SATB1 inhibits the invasion and growth of DU-145 cells. A - D : The invasion of DU-145 cells was measured by Transwell chamber. A, DU-145 cells untransfected. B , DU-145 cells transfected with pSliencer3.1. C , DU-145 cells transfected with pSilencer3.1-SATB1. Magnification: 200×. D : Quantitative analysis of the number of invaded cells as shown in A - C (n = 3). E : The proliferation of DU-145 cells was determined by CCK8 assay (n = 3). The cell proliferation inhibition rate was calculated for DU-145 cells at 24 h, 48 h and 72 h after transfection with pSilencer3.1-SATB1. *P < 0.05 compared to cells transfected with pSliencer3.1.

    Journal: Journal of Translational Medicine

    Article Title: SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion

    doi: 10.1186/1479-5876-11-111

    Figure Lengend Snippet: Silencing of SATB1 inhibits the invasion and growth of DU-145 cells. A - D : The invasion of DU-145 cells was measured by Transwell chamber. A, DU-145 cells untransfected. B , DU-145 cells transfected with pSliencer3.1. C , DU-145 cells transfected with pSilencer3.1-SATB1. Magnification: 200×. D : Quantitative analysis of the number of invaded cells as shown in A - C (n = 3). E : The proliferation of DU-145 cells was determined by CCK8 assay (n = 3). The cell proliferation inhibition rate was calculated for DU-145 cells at 24 h, 48 h and 72 h after transfection with pSilencer3.1-SATB1. *P < 0.05 compared to cells transfected with pSliencer3.1.

    Article Snippet: The sections were blocked with 2% goat serum in 0.01 M PBS at room temperature for 1 h, then incubated with rabbit polyclonal anti-SATB1 antibody (1:500 dilution, NB110-17780, Novus Biologicals, Littleton, CO, USA) overnight at 4°C.

    Techniques: Transfection, CCK-8 Assay, Inhibition

    Reconstitution of SATB1 expression in LNCaP cells. LNCaP cells were untransfected (control), transfected with pcDNA3.1 control vector or transfected with pcDNA3.1-SATB1 vector for 12 h, 24 h, or 36 h. A . The mRNA level of SATB1 was detected by RT-PCR (n = 3). B . The protein level of SATB1 was detected by Western blot analysis (n = 3). β-actin served as loading control. *P < 0.05 compared to cells transfected with pcDNA3.1.

    Journal: Journal of Translational Medicine

    Article Title: SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion

    doi: 10.1186/1479-5876-11-111

    Figure Lengend Snippet: Reconstitution of SATB1 expression in LNCaP cells. LNCaP cells were untransfected (control), transfected with pcDNA3.1 control vector or transfected with pcDNA3.1-SATB1 vector for 12 h, 24 h, or 36 h. A . The mRNA level of SATB1 was detected by RT-PCR (n = 3). B . The protein level of SATB1 was detected by Western blot analysis (n = 3). β-actin served as loading control. *P < 0.05 compared to cells transfected with pcDNA3.1.

    Article Snippet: The sections were blocked with 2% goat serum in 0.01 M PBS at room temperature for 1 h, then incubated with rabbit polyclonal anti-SATB1 antibody (1:500 dilution, NB110-17780, Novus Biologicals, Littleton, CO, USA) overnight at 4°C.

    Techniques: Expressing, Control, Transfection, Plasmid Preparation, Reverse Transcription Polymerase Chain Reaction, Western Blot

    Overexpression of SATB1 promotes the invasion and growth of LNCaP cells. A - D : The invasion of LNCaP cells was measured by Transwell chamber. A , LNCaP cells untransfected. B , LNCaP cells transfected with pcDNA3.1. C , LNCaP cells transfected with pcDNA3.1-SATB1. Magnification: 200×. D : Quantitative analysis of the number of invaded cells as shown in A - C (n = 3). *P < 0.05 compared to cells transfected with pcDNA3.1. E : The proliferation of LNCaP cells was determined by CCK8 assay (n = 3). The cell proliferation ratio was calculated for LNCaP cells at 24 h, 48 h and 72 h after transfection of pcDNA3.1 or pcDNA3.1-SATB1. *P < 0.05 compared to corresponding cells transfected with pcDNA3.1.

    Journal: Journal of Translational Medicine

    Article Title: SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion

    doi: 10.1186/1479-5876-11-111

    Figure Lengend Snippet: Overexpression of SATB1 promotes the invasion and growth of LNCaP cells. A - D : The invasion of LNCaP cells was measured by Transwell chamber. A , LNCaP cells untransfected. B , LNCaP cells transfected with pcDNA3.1. C , LNCaP cells transfected with pcDNA3.1-SATB1. Magnification: 200×. D : Quantitative analysis of the number of invaded cells as shown in A - C (n = 3). *P < 0.05 compared to cells transfected with pcDNA3.1. E : The proliferation of LNCaP cells was determined by CCK8 assay (n = 3). The cell proliferation ratio was calculated for LNCaP cells at 24 h, 48 h and 72 h after transfection of pcDNA3.1 or pcDNA3.1-SATB1. *P < 0.05 compared to corresponding cells transfected with pcDNA3.1.

    Article Snippet: The sections were blocked with 2% goat serum in 0.01 M PBS at room temperature for 1 h, then incubated with rabbit polyclonal anti-SATB1 antibody (1:500 dilution, NB110-17780, Novus Biologicals, Littleton, CO, USA) overnight at 4°C.

    Techniques: Over Expression, Transfection, CCK-8 Assay

    AGR2 transcript expression in prostate cancer . Two publically available datasets were used to examine AGR2 gene expression in human prostate samples [ , ]. (A) Dataset was from Yu, et al ., and was generated using Affymetrix U95B Array . (B) Dataset was from Lapointe, et al ., and was generated using a cDNA microarray from the Stanford Microarray Database . For each dataset, normalized data was available from the GEO database. The bars are the relative mean expression value ± standard error of the mean. P < 0.0001 for each multi group comparison (Kruskal-Wallis).

    Journal: BMC Cancer

    Article Title: Differential expression of anterior gradient gene AGR2 in prostate cancer

    doi: 10.1186/1471-2407-10-680

    Figure Lengend Snippet: AGR2 transcript expression in prostate cancer . Two publically available datasets were used to examine AGR2 gene expression in human prostate samples [ , ]. (A) Dataset was from Yu, et al ., and was generated using Affymetrix U95B Array . (B) Dataset was from Lapointe, et al ., and was generated using a cDNA microarray from the Stanford Microarray Database . For each dataset, normalized data was available from the GEO database. The bars are the relative mean expression value ± standard error of the mean. P < 0.0001 for each multi group comparison (Kruskal-Wallis).

    Article Snippet: Slides were incubated with rabbit polyclonal anti-AGR2 antibody at 1:400 (NB110-17780, Novus Biologicals, Littleton, CO) overnight at 4°C.

    Techniques: Expressing, Gene Expression, Generated, Microarray, Comparison

    AGR2 immunohistochemistry . AGR2 staining was localized to the cytoplasm and membrane of cancer epithelial cells. (A) Tissue samples incubated with concentration-matched non-immune rabbit IgG showed no staining. Shown are representative sections of (B) morphologically normal tissue, (C) PIN, and (D) a representative adenocarcinoma (Gleason grade 7) showing low staining intensity, (E) a representative adenocarcinoma (Gleason grade 8) showing moderate staining intensity, and (F) a representative adenocarcinoma (Gleason grade 6) showing high staining intensity.

    Journal: BMC Cancer

    Article Title: Differential expression of anterior gradient gene AGR2 in prostate cancer

    doi: 10.1186/1471-2407-10-680

    Figure Lengend Snippet: AGR2 immunohistochemistry . AGR2 staining was localized to the cytoplasm and membrane of cancer epithelial cells. (A) Tissue samples incubated with concentration-matched non-immune rabbit IgG showed no staining. Shown are representative sections of (B) morphologically normal tissue, (C) PIN, and (D) a representative adenocarcinoma (Gleason grade 7) showing low staining intensity, (E) a representative adenocarcinoma (Gleason grade 8) showing moderate staining intensity, and (F) a representative adenocarcinoma (Gleason grade 6) showing high staining intensity.

    Article Snippet: Slides were incubated with rabbit polyclonal anti-AGR2 antibody at 1:400 (NB110-17780, Novus Biologicals, Littleton, CO) overnight at 4°C.

    Techniques: Immunohistochemistry, Staining, Membrane, Incubation, Concentration Assay

    AGR2 expression by spot level histopathology . The barplots show the mean integrated AGR2 expression by TMA spot-level histology in morphologically normal (NL), BPH, PIN, adenocarcinoma (AD), and lymph node metastases (LNMET); bars are standard errors. Levels of AGR2 expression were increased in PIN lesions and adenocarcinoma compared to BPH and morphologically normal adjacent tissue (P < 0.0001). Regional metastases showed increased AGR2 expression compared to BPH and normal tissue (P = 0.027 and P = 0.030, respectively).

    Journal: BMC Cancer

    Article Title: Differential expression of anterior gradient gene AGR2 in prostate cancer

    doi: 10.1186/1471-2407-10-680

    Figure Lengend Snippet: AGR2 expression by spot level histopathology . The barplots show the mean integrated AGR2 expression by TMA spot-level histology in morphologically normal (NL), BPH, PIN, adenocarcinoma (AD), and lymph node metastases (LNMET); bars are standard errors. Levels of AGR2 expression were increased in PIN lesions and adenocarcinoma compared to BPH and morphologically normal adjacent tissue (P < 0.0001). Regional metastases showed increased AGR2 expression compared to BPH and normal tissue (P = 0.027 and P = 0.030, respectively).

    Article Snippet: Slides were incubated with rabbit polyclonal anti-AGR2 antibody at 1:400 (NB110-17780, Novus Biologicals, Littleton, CO) overnight at 4°C.

    Techniques: Expressing, Histopathology

    AGR2 expression by spot level Gleason grade . The barplots show the mean integrated AGR2 expression by TMA spot-level Gleason grade; bars are standard errors. Average AGR2 expression was increased in grades 3 and 4 compared to grade 2 (P < 0.0001 and P = 0.0007) and grade 5 (P = 0.0028 and P = 0.0085).

    Journal: BMC Cancer

    Article Title: Differential expression of anterior gradient gene AGR2 in prostate cancer

    doi: 10.1186/1471-2407-10-680

    Figure Lengend Snippet: AGR2 expression by spot level Gleason grade . The barplots show the mean integrated AGR2 expression by TMA spot-level Gleason grade; bars are standard errors. Average AGR2 expression was increased in grades 3 and 4 compared to grade 2 (P < 0.0001 and P = 0.0007) and grade 5 (P = 0.0028 and P = 0.0085).

    Article Snippet: Slides were incubated with rabbit polyclonal anti-AGR2 antibody at 1:400 (NB110-17780, Novus Biologicals, Littleton, CO) overnight at 4°C.

    Techniques: Expressing

    Univariate Cox model

    Journal: BMC Cancer

    Article Title: Differential expression of anterior gradient gene AGR2 in prostate cancer

    doi: 10.1186/1471-2407-10-680

    Figure Lengend Snippet: Univariate Cox model

    Article Snippet: Slides were incubated with rabbit polyclonal anti-AGR2 antibody at 1:400 (NB110-17780, Novus Biologicals, Littleton, CO) overnight at 4°C.

    Techniques:

    AGR2 levels predict prostate cancer recurrence in high stage patients . Solid line is relatively higher AGR2 levels (staining measure ≥0.79); dashed line is relatively lower AGR2 levels (< 0.79). In men with stage III or IV prostate cancer, relatively lower levels of AGR2 predict a significantly greater chance of prostate cancer recurrence compared to those with higher levels (P = 0.009).

    Journal: BMC Cancer

    Article Title: Differential expression of anterior gradient gene AGR2 in prostate cancer

    doi: 10.1186/1471-2407-10-680

    Figure Lengend Snippet: AGR2 levels predict prostate cancer recurrence in high stage patients . Solid line is relatively higher AGR2 levels (staining measure ≥0.79); dashed line is relatively lower AGR2 levels (< 0.79). In men with stage III or IV prostate cancer, relatively lower levels of AGR2 predict a significantly greater chance of prostate cancer recurrence compared to those with higher levels (P = 0.009).

    Article Snippet: Slides were incubated with rabbit polyclonal anti-AGR2 antibody at 1:400 (NB110-17780, Novus Biologicals, Littleton, CO) overnight at 4°C.

    Techniques: Staining

    Clinicopathologic parameters and  AGR2  expression in patients with high stage prostate cancer

    Journal: BMC Cancer

    Article Title: Differential expression of anterior gradient gene AGR2 in prostate cancer

    doi: 10.1186/1471-2407-10-680

    Figure Lengend Snippet: Clinicopathologic parameters and AGR2 expression in patients with high stage prostate cancer

    Article Snippet: Slides were incubated with rabbit polyclonal anti-AGR2 antibody at 1:400 (NB110-17780, Novus Biologicals, Littleton, CO) overnight at 4°C.

    Techniques: Expressing

    Multivariate Cox model

    Journal: BMC Cancer

    Article Title: Differential expression of anterior gradient gene AGR2 in prostate cancer

    doi: 10.1186/1471-2407-10-680

    Figure Lengend Snippet: Multivariate Cox model

    Article Snippet: Slides were incubated with rabbit polyclonal anti-AGR2 antibody at 1:400 (NB110-17780, Novus Biologicals, Littleton, CO) overnight at 4°C.

    Techniques:

    Clinicopathologic parameters and  AGR2  expression in patients with prostate cancer

    Journal: BMC Cancer

    Article Title: Differential expression of anterior gradient gene AGR2 in prostate cancer

    doi: 10.1186/1471-2407-10-680

    Figure Lengend Snippet: Clinicopathologic parameters and AGR2 expression in patients with prostate cancer

    Article Snippet: Slides were incubated with rabbit polyclonal anti-AGR2 antibody at 1:400 (NB110-17780, Novus Biologicals, Littleton, CO) overnight at 4°C.

    Techniques: Expressing